La biopsia endomiocardica nella miocardite acuta: Per alcuni ma non per tutti i pazienti

Translated title of the contribution: Endomyocardial biopsy in acute myocarditis: For some but not for all patients

Enrico Ammirati, Manlio Cipriani, Edgardo Bonacina, Andrea Garascia, Fabrizio Oliva

Research output: Contribution to journalArticlepeer-review

Abstract

Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.

Translated title of the contributionEndomyocardial biopsy in acute myocarditis: For some but not for all patients
Original languageItalian
Pages (from-to)539-543
Number of pages5
JournalGiornale Italiano di Cardiologia
Volume16
Issue number10
DOIs
Publication statusPublished - Oct 1 2015

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Endomyocardial biopsy in acute myocarditis: For some but not for all patients'. Together they form a unique fingerprint.

Cite this